Artificial Intelligence in Genomics Market - Global Forecast to 2036

According to the research report titled, 'Artificial Intelligence in Genomics Market by Offering (Software, Services), Functionality (Genome Sequencing, Gene Editing, Genome Assembly & Annotation, Pharmacogenomics), Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Agricultural Genomics), Delivery Mode (On-premises, Cloud & Web-Based), and End User - Global Forecast to 2036,' the global artificial intelligence in genomics market is expected to reach approximately USD 19.96 billion by 2036 from USD 1.90 billion in 2026, at a CAGR of 26.5% during the forecast period (2026-2036). The report provides an in-depth analysis of the global artificial intelligence in genomics market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the artificial intelligence in genomics market include the increasing volume of genomic data generated by next-generation sequencing technologies and the limitations of traditional bioinformatics tools. Additionally, the rapid growth of AI-driven precision medicine and increasing investment in drug discovery are expected to create significant growth opportunities for players operating in the artificial intelligence in genomics market.

Market Segmentation

The artificial intelligence in genomics market is segmented by offering (software, services), functionality (genome sequencing, gene editing, genome assembly & annotation, pharmacogenomics, others), application (drug discovery & development, precision medicine, diagnostics, agricultural genomics, others), delivery mode (on-premises, cloud & web-based), and end user. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Offering

By offering, the software segment holds the largest market share in 2026, primarily driven by the increasing demand for AI-powered genomic interpretation platforms, automated variant calling tools, and cloud-native bioinformatics software. Software solutions represent the primary market driver for the AI in genomics industry. However, the services segment is expected to grow at a significant CAGR during the forecast period, driven by the increasing demand for specialized bioinformatics consulting, AI model customization, and managed genomic data analysis services to support clinical research and drug development.

Based on Functionality

By functionality, the genome sequencing segment holds the largest market share in 2026, reflecting the fundamental role of AI in processing massive raw sequencing datasets and improving the accuracy of base calling and variant detection. Genome sequencing represents the primary functionality for AI in genomics. The gene editing and pharmacogenomics segments are expected to witness significant growth during the forecast period, supported by the increasing use of AI to predict off-target effects in CRISPR-based therapies and to optimize personalized drug regimens based on genomic profiles.

Based on Application

By application, the drug discovery & development segment holds the largest market share in 2026, owing to the massive potential of AI in identifying novel therapeutic targets and accelerating the lead optimization process through genomic insights. Drug discovery & development represents the primary application for AI in genomics. The precision medicine and diagnostics segments are expected to witness the fastest growth during the forecast period, driven by the increasing clinical adoption of genomic-based diagnostics for oncology and rare diseases.

Based on Delivery Mode

By delivery mode, the cloud & web-based segment holds the largest market share in 2026, primarily attributed to the high computational requirements of genomic analysis and the scalability offered by cloud platforms for managing large-scale population genomics data. Cloud-based delivery represents the most prevalent category in the AI in genomics market. The on-premises segment continues to represent a significant portion of the market, particularly among large research institutions and healthcare organizations that prioritize data sovereignty and internal control over sensitive patient genomic data.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global artificial intelligence in genomics market with the largest market share, primarily attributed to the high concentration of biotech and AI companies, robust research funding, and the early adoption of precision medicine in the U.S. and Canada. Europe maintains a significant market share, supported by large-scale national genomics initiatives. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by rapidly expanding healthcare infrastructure and increasing genomic research investments in China, India, and Japan. Latin America and the Middle East & Africa represent emerging markets with growing emphasis on genomic health programs.

Key Players

The key players operating in the global artificial intelligence in genomics market are NVIDIA Corporation, IBM Corporation, Microsoft Corporation, Google LLC, Illumina Inc., Tempus AI Inc., GeneDx Inc., Fabric Genomics Inc., Sophia Genetics SA, BenevolentAI, Freenome Holdings Inc., Deep Genomics, and various other regional and emerging AI-driven biotechnology providers, among others.

Key Questions Answered in the Report

• What is the current revenue generated by the artificial intelligence in genomics market globally?
• At what rate is the global artificial intelligence in genomics market demand projected to grow for the next 7-10 years?
• What are the historical market sizes and growth rates of the global artificial intelligence in genomics market?
• What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
• Which segments in terms of offering, functionality, application, and delivery mode are expected to create major traction for the service providers in this market?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global artificial intelligence in genomics market?
• Who are the major players in the global artificial intelligence in genomics market? What are their specific product offerings in this market?
• What are the recent strategic developments in the global artificial intelligence in genomics market? What are the impacts of these strategic developments on the market?

Scope of the Report:

AI in Genomics Market Assessment - by Offering

• Software
• Services

AI in Genomics Market Assessment - by Functionality

• Genome Sequencing
• Gene Editing
• Genome Assembly & Annotation
• Pharmacogenomics
• Others

AI in Genomics Market Assessment - by Application

• Drug Discovery & Development
• Precision Medicine
• Diagnostics
• Agricultural Genomics
• Others

AI in Genomics Market Assessment - by Delivery Mode

• On-premises
• Cloud & Web-Based

AI in Genomics Market Assessment - by Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Australia
• Southeast Asia
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East & Africa